GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.
100% less funds holding
Funds holding: 297 → 1 (-296)
100% less funds holding in top 10
Funds holding in top 10: 21 → 0 (-21)
100% less capital invested
Capital invested by funds: $5.23B → $3K (-$5.23B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 294
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$456M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$325M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
-$292M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$277M |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$212M |
GWPH Hedge Fund Activity: Q2 2021 in Review
1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.
Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.
- 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
- Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.
Based on aggregated 13F filings for Q2 2021.